Latest News

Mecasermin treatment for Rett Syndrome is safe, well-tolerated

A Phase 1 clinical trial using mecasermin [recombinant human insulin-like growth factor 1 (IGF-1)] has been completed for Rett Syndrome research, showing proof-of-principle that treatments like IGF-1 which are based on the neurobiology of Rett syndrome, are possible.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Brain Secrets Unlocked by International Imaging Effort

  • Estrogen-producing neurons influence aggression in both sexes

  • Secrets of a clump-dissolving protein uncovered

  • Family voices, stories speed coma recovery

  • Prescription painkillers, widely used by childbearing age women, double birth defects risk

  • Low-income boys fare worse in wealth's shadow

  • Tablet computers good medium for educational materials

  • Anti-inflammatory protein may trigger plaque in Alzheimer's disease

  • Pro-marijuana 'tweets' are sky-high on Twitter

  • Genome-wide search reveals new genes involved in long-term memory

  •